Partner News
The section includes updates from partner organizations on related advocacy efforts.
Materials in this section
Hepatitis C Epidemic Among Rohingya Refugees in Cox’s Bazar: A Public Health Emergency
International health organisations are struggling to respond to an alarming epidemic of hepatitis C in Rohingya refugees in Cox’s Bazar, Bangladesh. More
EHRC2024: Recordings of the Streamed Sessions Now Available Online
Thanks to Drugreporter, selected sessions were available to watch via streaming during the 6th European Harm Reduction Conference (EHRC2024), and their recordings can now be accessed online. More
INHSU 2024: Hepatitis C Key Takeaways
INHSU 2024 heard from global experts on innovative strategies to eliminate hepatitis C, including groundbreaking approaches to testing, treatment, and data collection. More
Accessible DAAs Shouldn’t Be DOA: Delivering on the Promise of Negotiated Price Reductions for HCV Treatment
The hepatitis C virus remains one of the deadliest infectious diseases, despite the existence of an effective eight-to-twelve week cure. Access to direct acting antivirals must be urgently expanded to save lives. More
WHO Prequalifies the First Self-Test for Hepatitis C Virus
WHO has prequalified the first HCV self-test which can provide a critical support in expanding access to testing and diagnosis, accelerating global efforts to eliminate hepatitis C. More
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
Test Enables Single-Visit Testing and Treatment for Hepatitis C. More
From Principle to Practice: Involving Communities in Research Design for Effective Hepatitis C Prevention
Unitaid’s funding to support the integration of hepatitis C testing and treatment in harm reduction services, while trialing the use of two underused products to prevent infection. More
ECDC: High Burden of Hepatitis B and C Persists in the EU/EEA
Recent ECDC data show that despite progress in prevention and control efforts, hepatitis B and C continue to pose significant public health challenges in the European Union and European Economic Area. More
Digitalized Community-led Monitoring - HIV/HBV/HCV in India and Indonesia
TREAT Asia/amfAR is implementing the Community-led Monitoring in Asia project, an online data dashboard to enhance ongoing community-led monitoring in India and Indonesia, including HBV and HCV indicators. More
Barriers to a Cure: Study Reveals Global Obstacles to Getting Hep C Treatment
A study provides new evidence regarding the registration and reimbursement of HCV therapies, including restrictions on reimbursement, permitting multicountry analyses and highlighting areas for growth. More
